Program Description
Chronic obstructive pulmonary disease (COPD) is often underdiagnosed and discovered late in the disease's progression, leading to inadequate treatment. Despite COPD being underdiagnosed globally, pharmacists can significantly improve patient outcomes, lower health care costs, and reduce the burden of COPD through early disease identification and timely therapeutic interventions. Pharmacists can improve COPD management through counseling on medication adherence, optimizing medicine delivery, and providing patient-focused treatment. This webinar will review therapies for COPD treatment and guideline-based strategies to ensure personalized management, considering factors such as comorbidities, polypharmacy, and adverse effects. Multidisciplinary strategies to support shared decision-making and adherence to prescribed treatments will be emphasized.
Target audience: Ambulatory care, community, and retail pharmacists
Type of activity: Application
Release date: January 30, 2025
Expiration date: March 30, 2025
Time to complete activity: 1.0 hour
Learner level: Foundational
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Analyze current chronic obstructive pulmonary disease (COPD) recommendations and guidelines effectively within clinical practice
- Apply personalized approaches for selecting the most suitable inhaled maintenance treatment for patients with COPD, considering individual symptomatology and risk of exacerbations
- Employ strategies to maintain continuity of care for patients with COPD who are transitioning between inpatient and outpatient settings
